Connection

JASON KIMATA to HIV Antibodies

This is a "connection" page, showing publications JASON KIMATA has written about HIV Antibodies.
Connection Strength

1.149
  1. Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity. J Virol. 2018 04 01; 92(7).
    View in: PubMed
    Score: 0.588
  2. Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms. Front Immunol. 2023; 14:1167965.
    View in: PubMed
    Score: 0.215
  3. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1. J Virol. 2016 Dec 01; 90(23):10642-10659.
    View in: PubMed
    Score: 0.134
  4. Trimeric glycosylphosphatidylinositol-anchored HCDR3 of broadly neutralizing antibody PG16 is a potent HIV-1 entry inhibitor. J Virol. 2013 Feb; 87(3):1899-905.
    View in: PubMed
    Score: 0.102
  5. GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike. Retrovirology. 2010 Oct 06; 7:79.
    View in: PubMed
    Score: 0.088
  6. Potent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16. J Virol. 2011 Sep; 85(17):8467-76.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.